Katherine Falkenhagen, PhD

Patent Agent
Norton Rose Fulbright US LLP
kathy.falkenhagen@nortonrosefulbright.com
Kathy
Falkenhagen
Katherine Falkenhagen, PhD
Los Angeles
Forty-First Floor
555 South Flower Street
Los Angeles, California
90071
United States
+1 213 892 9256

Kathy Falkenhagen combines her scientific training with extensive patent experience to secure and protect her clients’ intellectual property. Her practice focuses on patent prosecution in the biotechnology and life sciences sectors, encompassing molecular biology, genomics, therapeutics, diagnostics, medical devices, plant science, agricultural/food technologies and cosmetics. She assists clients ranging from research institutes and universities to biotechnology companies of all sizes, and has also worked with plant breeders and individual inventors.

Prior to her career as a patent agent, Kathy earned her PhD in Biomedical Sciences from UC San Diego, conducting research in the Peptide Biology Laboratory at the Salk Institute where she designed and completed projects investigating metabolic roles of peptides using a wide range of physiological models, cell culture systems and molecular biology techniques. This scientific background gives her an invaluable understanding of the biotech industry and enables her to effectively communicate with inventors and navigate complex technical subject matter across diverse patent types and technologies. She now assists clients with patent portfolio management, patent prosecution, USPTO proceedings including examiner interviews and appeals, patentability analyses, IP strategy development, competitor portfolio monitoring, freedom to operate analyses, due diligence and collaboration with foreign associates for worldwide patent filings.

Representative experience

  • Experience with various therapeutic technologies, including CAR T cell platforms and cell based applications.
  • Experience with organoid based technologies, including stem cell derived organoids for hematopoietic, intestinal, hepatic, neural and retinal and other tissue systems.
  • Experience with formulation technologies, including cosmetic formulations and pesticide formulations.
  • Experience with cell‑based therapeutic technologies, including CAR‑T cell platforms and fibroblast‑based applications.
  • Experience with nucleic acid‑based therapeutics and diagnostics, including patent drafting and prosecution related to mitochondrial RNA (mtRNA) technologies and gene expression‑based diagnostic approaches.
  • Experience with plant‑ and algae‑based technologies, including engineered plants, biomass derived from algae and novel plant varieties, plant‑derived products and formulations (including hemp seed processing and therapeutic compounds), cosmetic applications and algae‑based biofuels.

Education

  • PhD, Biomedical Sciences, University of California - San Diego
  • BA, Biology, Willamette University

Admissions

  • US Patent and Trademark Agent
Bio